Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Milk powder may reshape gut bacteria in middle age, study hints

NCT ID NCT07575529

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This study tests whether a daily milk powder containing probiotics and prebiotics can change the gut bacteria of healthy adults aged 40 to 65. About 100 participants in Singapore will drink the powder twice a day for at least 28 days. Researchers will compare stool samples, blood tests, sleep, activity, and thinking skills before and after the intervention to see if the drink makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
synbiotic nutritional product (probiotic and prebiotic blend in milk powder)
What this could lead to
If successful, this could show that a daily synbiotic drink supports a healthier gut microbiome in middle-aged and older adults, pointing toward simple dietary strategies for healthy aging.
What could go wrong
This is a small, early exploratory study with no placebo group, so results may be due to chance or other factors. It only looks at short-term changes (28-35 days) and cannot prove long-term benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Participants aged between 40 to 65 years (bounds included) 2. Participants who are community-living 3. Participants who are in good health (self-reported) 4. Participants own and are willing to use their personal non-shared mobile device (iPhone 8 or later, with iOS version 16 or later), to pair with the study-provided Apple Watch SE, for the duration of the study 5. Participant should be able to use mobile applications on smartphones to perform tasks in the study, have access to the internet and a smartphone or tablet to take and upload images and/or videos of stool, and other anatomical sites 6. Participant should be able to comprehend the content of the study and to complete the study questionnaires in English 7. Written and signed consent from participant 8. Currently reside in Singapore and with the intention to reside in Singapore for at least the duration of the study. Note: Clinical trial participants may be permitted to undertake short-duration travel not exceeding 72 consecutive hours each time, provided such travel does not conflict with scheduled study visits, investigational product administration, or protocol-defined assessments. Prior notification to principal investigator or designated study personnel is required. The participant must be instructed on potential risks, adverse event reporting during the travel period. Exclusion Criteria: 1. Pregnant or lactating, or wish to become pregnant during the period of the study (self-reported) 2. Participant with current or intended participation in a clinical study involving investigational or marketed products 3. Use of named prebiotics, probiotics or synbiotics (in a capsule or sachet) within the last 4 weeks prior to screening or are planning to use it during the study including but not limited to the products listed below: * BioGaia Probiotic Tablets * LACTO FIT Probiotics * Nano Singapore Digestive Wellness Formula * California Gold Nutrition LactoBif Probiotics * Life Space Probiotic * Vivomixx 112.5 Billion Live Probiotics * Duolac Daily Vitality Probiotic * ATOMY Probiotics 10+ * Blackmores Ultra Max Probiotics+ * Holistic Way High Strength Probiotic 75 Billion 4. Use of any commercial healthy aging milk powder within the last 4 weeks prior to screening or are planning to use it during the study including but not limited to: * Boost Optimum * Enercal complete * Anlene * Ensure 5. Use of systemic antibiotics within the last 8 weeks prior to screening 6. Known allergy or intolerance to Galactooligosaccharides (GOS), lactose, probiotics, or any ingredient in the SP 7. Gastrointestinal (GI) surgery within the last 6 months prior to screening 8. BMI below 18.5 kg/m² or above 27.5 kg/m² 9. Participants who are using insulin, or have poorly controlled diabetes (HbA1c ≥ 10%) within last 3 months prior to screening 10. Other severe disease(s) impairing activities of daily living or affecting the ability to complete the study assessments such as malignancy, end stage organ failure, COPD on long-term oxygen therapy, stroke with significantly residual functional weakness, cardiac failure with poor effort tolerance, significant neurological disease such as cognitive impairment from dementia, severe neuromuscular disease like Parkinson's disease, psychiatric disease/disorder, auto-immune disease, allergic conditions requiring chronic systemic medication, other severe GI disease(s) such as Crohn's disease, GI cancer, or ulcerative colitis diagnosed by a physician 11. History of drug abuse (Drug Abuse Screening Test (DAST) score of \>2) or alcohol abuse (Alcohol Use Disorders Identification Test (AUDIT) score of \> 7) within the last 6 months prior to screening 12. Participants on a special diet, e.g., vegan, low-carbohydrate for intentional weight loss, ketogenic, low-FODMAP diet at the screening visit, or plan for such diet during the study duration 13. Employees and/or children/family members or relatives of employees of Danone or the study team members (dependent relationship with study team members) participating sites such as, employees of the Investigator or of the Sponsor, members of the armed forces, and persons kept in detention 14. Participant expected to be living in the same home as a current participating participant and to concomitantly receive SP

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AI are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Woodland Hospital

    RECRUITING

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.